Synthesis and Antiproliferative Ativity of 2,4-Bis(indol-3-yl)pyrrole Derivatives: Marine Nortopsentin Analogs | ||
| Egyptian Journal of Chemistry | ||
| Article 67, Volume 64, Issue 8, August 2021, Pages 4697-4706 PDF (669.98 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejchem.2021.84060.4117 | ||
| Authors | ||
| Mohamed Rdwan* 1; Osama alrugaie2; Waleed Al Abdulmonem3; Mohammad Alfaifi4; Serag Eldin Elbehairi5 | ||
| 1Department of Applied Organic Chemistry, National Research Center, Dokki 12622, Egypt | ||
| 2Department of Basic Medical Sciences, Unaizah College of Medicine and Medical Sciences, Qassim University, Unaizah, Saudi Arabia | ||
| 3Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi Arabia. (dr.waleedmonem@qu.edu.sa) | ||
| 4King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia | ||
| 5Cell Culture Lab, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), 51 Wezaret El-Zeraa St., Agouza, Giza, Egypt | ||
| Abstract | ||
| Abstract In this study, a series of nortopsentin analogs (2,4-bis(indol-3-yl)pyrrole derivatives) were designed, synthesized, and tested for their in vitro cytotoxic activity against three cell lines: human prostate adenocarcinoma (PC-3), human ovary adenocarcinoma (SKOV3), and human Dukes' type B colorectal adenocarcinoma (LS-174T). Compounds 5a, 5e, 5h, 5j, and 5k had stronger antiproliferative activity against SKOV3, compound 5h and 5b against LS-174T, and compound 5e against PC-3 than the known doxorubicin drug. As a result, this work provides the framework for further research into 2,4-bis(indol-3-yl)pyrrole derivatives as antiproliferative drugs. | ||
| Keywords | ||
| Indole; bisindole; nortopsentin; pyrrole; antiproliferative | ||
|
Statistics Article View: 359 PDF Download: 431 |
||